Experts predict that physicians may favour emerging biosimilar versions of Stelara over more effective originator IL-23 drugs ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

AbbVie stock fell 10% after emraclidine, its drug for schizophrenia, failed during the final stages of its trials. The ...

Researchers used pharmacovigilance data to examine the onset of gastrointestinal adverse events associated with the use of biologic therapies for psoriasis.

"Salicylic acid is a topical medication used to treat acne and a variety of other skin conditions, like warts and psoriasis," ...

The use of IL-17 inhibitors in patients with psoriasis was associated with an increased risk for fungal infections when compared with other biologics.

And that the waiting list to see a dermatologist was 77 weeks ... When Emmy started the new medication she found her ...

By AUT Journalism Student Vivek Panchal The Government has announced it will increase funding for Pharmac, boosting ...

The mum was diagnosed with psoriasis and put on a dose of medication that cleared up her symptoms within ... The GP kept ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

psoriasis, and Crohn’s. A few days ago, ABBV was trading around $200, but its price has dropped by more than 12% in the last month, primarily due to emraclidine’s disappointing clinical trial results.